Author:
Findlay M.P.N.,Raynaud F.,Cunningham D.,Iveson A.,Collins D.J.,Leach M.O.
Reference23 articles.
1. Phase I study of protracted venous infusion of 5-fluorouracil;Lokich;Cancer,1981
2. Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics;Spicer;Cancer Res,1988
3. Relationship between di-hydropyrimidine dehydrogenase activity and plasma 5-fluor-ouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion;Harris;Cancer Res,1990
4. Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: Evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation;Sparano;J Clin Oncol,1993
5. Determination of 5-fluorouracil and its main metabolites in plasma by high-per-formance liquid chromatography;Barberi-Heyob;J Chromotogr,1992
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献